Skip to main content

and
Your search also matched 28 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Nicotinamide Inhibits Self-renewal and Induces Granulocyte Differentiation of Multipotent Progenitor Cells

Include preview-only content
  1. Article

    Open Access

    Activation of distinct inflammatory pathways in subgroups of LR-MDS

    Aberrant innate immune signaling has been identified as a potential key driver of the complex pathophysiology of myelodysplastic neoplasms (MDS). This study of a large, clinically and genetically well-characte...

    Marie Schneider, Clara Rolfs, Matthias Trumpp, Susann Winter, Luise Fischer in Leukemia (2023)

  2. Article

    Open Access

    Estimating prognostic relevant cutoff values for a multiplex PCR detecting BCR::ABL1 in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy in resource-limited settings

    The prognosis of chronic myeloid leukemia (CML) on tyrosine kinase inhibitor (TKI) treatment is based on the quantification of BCR::ABL1 fusion gene transcript copy number, harmonized by an international scale...

    Saifu Hailu, Samuel Kinde, Michael Cross, Aster Tsegaye in Annals of Hematology (2023)

  3. Article

    Open Access

    Optimized production, purification, and radiolabeling of the 203Pb/212Pb theranostic pair for nuclear medicine

    TRIUMF is one of the only laboratories in the world able to produce both lead-203 (203Pb, t1/2 = 51.9 h) and 212Pb (t1/2 = 10.6 h) onsite via its 13 and 500 MeV cyclotrons, respectively. Together, 203Pb and 212Pb...

    Brooke L. McNeil, Simona A. Mastroianni, Scott W. McNeil in Scientific Reports (2023)

  4. Article

    Open Access

    Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study

    A randomized inter-group trial comparing more intensive treatment strategies to a common standard arm 3 + 7 (CSA) was conducted in patients with non-M3 AML. Untreated patients ≥ 60 years were allocated to the ...

    Dietger Niederwieser, Thomas Lang, Rainer Krahl, Thomas Heinicke in Annals of Hematology (2023)

  5. Article

    Open Access

    Clonal hematopoiesis and cardiovascular disease: deciphering interconnections

    Cardiovascular and oncological diseases represent the global major causes of death. For both, a novel and far-reaching risk factor has been identified: clonal hematopoiesis (CH). CH is defined as clonal expans...

    Anna Stein, Klaus Metzeler, Anne Sophie Kubasch in Basic Research in Cardiology (2022)

  6. Article

    Open Access

    Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning—Eudract #: 2007-002420-15

    Saskia Hell, Madlen Jentzsch, Georg-Nikolaus Franke in Bone Marrow Transplantation (2022)

  7. Article

    Correction to: Allogeneic hematopoietic stem cell transplantation improves long‑term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials

    Thomas Heinicke, Rainer Krahl, Christoph Kahl, Michael Cross in Annals of Hematology (2021)

  8. Article

    Open Access

    Luspatercept restores SDF-1-mediated hematopoietic support by MDS-derived mesenchymal stromal cells

    The bone marrow microenvironment (BMME) plays a key role in the pathophysiology of myelodysplastic syndromes (MDS), clonal blood disorders affecting the differentiation, and maturation of hematopoietic stem an...

    Manja Wobus, Anna Mies, Nandini Asokan, Uta Oelschlägel, Kristin Möbus in Leukemia (2021)

  9. Article

    Open Access

    Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials

    Relapse of acute leukemia is a frequent complication with uncertain outcome and poorly defined risk factors. From 1621 patients entered into two prospective clinical trials (AML02; n = 740 and AML04; n = 881),...

    Thomas Heinicke, Rainer Krahl, Christoph Kahl, Michael Cross in Annals of Hematology (2021)

  10. Article

    Open Access

    Multi-curie production of gallium-68 on a biomedical cyclotron and automated radiolabelling of PSMA-11 and DOTATATE

    With increasing clinical demand for gallium-68, commercial germanium-68/gallium-68 ([68Ge]Ge/[68Ga]Ga) generators are incapable of supplying sufficient amounts of the short-lived daughter isotope. In this study, ...

    Helge Thisgaard, Joel Kumlin, Niels Langkjær in EJNMMI Radiopharmacy and Chemistry (2021)

  11. Article

    Inequities in German research system

    Michael Cross in Nature (1999)